APA (7th ed.) Citation

Ducreux, M., Davidenko, I., Bridgewater, J., Kupcinskas, L., Johannsdottir, H., van der Horst, T., . . . Propper, D. (2011). 6577 POSTER Investigating Potential Biomarkers for Survival With Erlotinib in Patients With Advanced Pancreatic Cancer – Results of the Phase II B021129 Study. European Journal of Cancer, 47, S464. https://doi.org/10.1016/S0959-8049(11)71888-3

Chicago Style (17th ed.) Citation

Ducreux, M., I. Davidenko, J. Bridgewater, L. Kupcinskas, H. Johannsdottir, T. van der Horst, B. Klughammer, and D. Propper. "6577 POSTER Investigating Potential Biomarkers for Survival With Erlotinib in Patients With Advanced Pancreatic Cancer – Results of the Phase II B021129 Study." European Journal of Cancer 47 (2011): S464. https://doi.org/10.1016/S0959-8049(11)71888-3.

MLA (9th ed.) Citation

Ducreux, M., et al. "6577 POSTER Investigating Potential Biomarkers for Survival With Erlotinib in Patients With Advanced Pancreatic Cancer – Results of the Phase II B021129 Study." European Journal of Cancer, vol. 47, 2011, p. S464, https://doi.org/10.1016/S0959-8049(11)71888-3.